Topical Reformulation of Valsartan for Treatment of Chronic Diabetic Wounds
Keywords: α-SMA; alpha-smooth muscle actin; ACE; angiotensin converting enzyme; ARB; angiotensin II type 1 receptors blocker; AT1R; angiotensin II type 1 receptors; AT2Râ/â; angiotensin II type 2 receptor knockout; MAPK; mitogen-activating protein kinase; RAS;